Search research articles
Contact Us
Filters
Showing results (51-60 of 56) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 56 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Biomarkers
Wang Yuchuan, Helen J Mitchell, Susi Lee, et al.
ACS Medicinal Chemistry Letters
|
July 19, 2023
Discovery of [<sup>11</sup>C]MK-8056: A Selective PET Imaging Agent for the Study of mGluR<sub>2</sub> Negative Allosteric Modulators
James J Perkins, Paul McQuade, Christopher J Bungard, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 5, 2020
MK-8719, a Novel and Selective <i>O</i>-GlcNAcase Inhibitor That Reduces the Formation of Pathological Tau and Ameliorates Neurodegeneration in a Mouse Model of Tauopathy
Xiaohai Wang, Wenping Li, Jacob Marcus, et al.
ACS Medicinal Chemistry Letters
|
January 17, 2024
Fluorinated Isoindolinone-Based Glucosylceramide Synthase Inhibitors with Low Human Dose Projections
H Marie Loughran, Kathy M Schirripa, Anthony J Roecker, et al.
ACS Chemical Neuroscience
|
August 4, 2012
Characterization of non-nitrocatechol pan and isoform specific catechol-O-methyltransferase inhibitors and substrates
Ronald G Robinson, Sean M Smith, Scott E Wolkenberg, et al.
ACS Medicinal Chemistry Letters
|
February 16, 2023
Pyrazole Ureas as Low Dose, CNS Penetrant Glucosylceramide Synthase Inhibitors for the Treatment of Parkinson's Disease
Anthony J Roecker, Kathy M Schirripa, H Marie Loughran, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 56) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 56 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Biomarkers
Wang Yuchuan, Helen J Mitchell, Susi Lee, et al.
ACS Medicinal Chemistry Letters
|
July 19, 2023
Discovery of [<sup>11</sup>C]MK-8056: A Selective PET Imaging Agent for the Study of mGluR<sub>2</sub> Negative Allosteric Modulators
James J Perkins, Paul McQuade, Christopher J Bungard, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 5, 2020
MK-8719, a Novel and Selective <i>O</i>-GlcNAcase Inhibitor That Reduces the Formation of Pathological Tau and Ameliorates Neurodegeneration in a Mouse Model of Tauopathy
Xiaohai Wang, Wenping Li, Jacob Marcus, et al.
ACS Medicinal Chemistry Letters
|
January 17, 2024
Fluorinated Isoindolinone-Based Glucosylceramide Synthase Inhibitors with Low Human Dose Projections
H Marie Loughran, Kathy M Schirripa, Anthony J Roecker, et al.
ACS Chemical Neuroscience
|
August 4, 2012
Characterization of non-nitrocatechol pan and isoform specific catechol-O-methyltransferase inhibitors and substrates
Ronald G Robinson, Sean M Smith, Scott E Wolkenberg, et al.
ACS Medicinal Chemistry Letters
|
February 16, 2023
Pyrazole Ureas as Low Dose, CNS Penetrant Glucosylceramide Synthase Inhibitors for the Treatment of Parkinson's Disease
Anthony J Roecker, Kathy M Schirripa, H Marie Loughran, et al.
Page
of 6